UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 75

Sortiert nach

Preparation and characterization of human HIV type 1 neutralizing reference sera

AIDS research and human retroviruses, 1995-07, Vol.11 (7), p.783-787

1995

Volltextzugriff (PDF)

Mutations in both gp120 and gp41 Are Responsible for the Broad Neutralization Resistance of Variant Human Immunodeficiency Virus Type 1 MN to Antibodies Directed at V3 and Non-V3 Epitopes

Journal of Virology, 1998-09, Vol.72 (9), p.7099-7107

1998

Volltextzugriff (PDF)

The phorbol ester phorbol myristate acetate inhibits human immunodeficiency virus type 1 envelope-mediated fusion by modulating an accessory component(s) in CD4-expressing cells

Journal of Virology, 1994-03, Vol.68 (3), p.1962-1969

1994

Volltextzugriff (PDF)

Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infection

AIDS research and human retroviruses, 1990-03, Vol.6 (3), p.341-356

1990

Volltextzugriff (PDF)

Use of a sensitive neutralization assay to measure the prevalence of antibodies to the human immunodeficiency virus

The Journal of infectious diseases, 1988-05, Vol.157 (5), p.1047

1988

Volltextzugriff (PDF)

Detection of human immunodeficiency virus core protein in plasma by enzyme immunoassay. Association of antigenemia with symptomatic disease and T-helper cell depletion

Annals of internal medicine, 1987-09, Vol.107 (3), p.286

1987

Volltextzugriff (PDF)

High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1MN in Sera from Africa and the Americas

AIDS research and human retroviruses, 1991-10, Vol.7 (10), p.831-838

1991

Volltextzugriff (PDF)

CD4-derived synthetic peptide blocks the binding of HIV-1 GP120 to CD4-bearing cells and prevents HIV-1 infection

Cellular immunology, 1990-06, Vol.128 (1), p.101-117

1990

Volltextzugriff (PDF)

Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays

Pediatrics (Evanston), 1983-09, Vol.72 (3), p.291

1983

Volltextzugriff (PDF)

International collaborative study to compare assays for antibodies that neutralize human immunodeficiency virus

AIDS research and human retroviruses, 1990-07, Vol.6 (7), p.847-853

1990

Volltextzugriff (PDF)

Human immunodeficiency virus neutralizing antibodies in sera from North Americans and Africans

Journal of acquired immune deficiency syndromes (1988), 1990, Vol.3 (8), p.810-816

1990

Volltextzugriff (PDF)

Comparison of the Raji cell line fluorescent antibody to membrane antigen test and the enzyme-linked immunosorbent assay for determination of immunity to varicella-zoster virus

Journal of Clinical Microbiology, 1982-11, Vol.16 (5), p.878-884

1982

Volltextzugriff (PDF)

Mutations in both gp120 and gp41 are responsible for the broad neutralization resistance of variant human immunodeficiency virus type 1mn to antibodies directed at v3 and non-v3 epitopes

Journal of virology, 1998-09, Vol.72 (9), p.7099-7107

1998

Volltextzugriff (PDF)

Chemically induced CD4 mutants of a human T cell line. Evidence for dissociation between binding of HIV I envelope and susceptibility to HIV I infection and syncytia formation

The Journal of immunology (1950), 1990-03, Vol.144 (6), p.2131

1990

Volltextzugriff (PDF)

Evaluation of humoral immunity to varicella-zoster virus by an enhanced neutralization test and by the fluorescent antibody to membrane antigen test

Archives of virology, 1983-01, Vol.75 (3), p.225-228

1983

Volltextzugriff (PDF)

Re-evaluation of the involvement of the adhesion molecules ICAM-1/LFA-1 in syncytia formation of HIV-1-infected subclones of a CEM T-cell leukemic line

AIDS research and human retroviruses, 1991-01, Vol.7 (1), p.45-53

1991

Volltextzugriff (PDF)

The phorbol ester phorbol myristate acetate inhibits human immunodeficiency virus type 1 envelope-mediated fusion by modulating an accessory component(s) in CD4-expresssing cells

Journal of virology, 1994-01, Vol.68 (3), p.1962-1969

1994

Volltextzugriff (PDF)

Varicella-zoster virus-specific HLA-restricted cytotoxicity of normal immune adult lymphocytes after in vitro stimulation

The Journal of infectious diseases, 1988-10, Vol.158 (4), p.780

1988

Volltextzugriff (PDF)

Study of viral replication in HIV-1-infected CEM T-cell subclones which are reduced in their ability to form syncytia: Clinical therapeutics in HIV disease

AIDS research and human retroviruses, 1992, Vol.8 (6), p.1139-1146

1992

Volltextzugriff (PDF)

Study of viral replication in HIV-1-infected CEM T-cell subclones which are reduced in their ability to form syncytia

AIDS research and human retroviruses, 1992-06, Vol.8 (6), p.1139-1146

1992

Volltextzugriff (PDF)

Ρe-evaluation of the involvement of the adhesion molecules ICAM-1/LFA-1 in syncytia formation of HIV-1-infected subclones of a CEM T-cell leukemic line

AIDS research and human retroviruses, 1991, Vol.7 (1), p.45-53

1991

Volltextzugriff (PDF)

High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1 sub(MN) in sera from Africa and the Americas

AIDS research and human retroviruses, 1991-01, Vol.7 (10), p.831-832

1991

Volltextzugriff (PDF)

Molecular landmarks of tumor hypoxia across cancer types

Nature genetics, 2019-02, Vol.51 (2), p.308-318

2019

Volltextzugriff (PDF)

Risk factors for multidrug-resistant tuberculosis among tuberculosis patients in Serbia: a case-control study

BMC public health, 2018-09, Vol.18 (1), p.1114-1114, Article 1114

2018

Volltextzugriff (PDF)

Tailor-made biocatalysts based on scarcely studied acidic horseradish peroxidase for biodegradation of reactive dyes

Environmental science and pollution research international, 2017-02, Vol.24 (4), p.3923-3933

2017

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(67)

Publikationsform

Artikel
(75)

Sprache

Englisch
(75)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

Science & Technology
(50)
Life Sciences & Biomedicine
(42)
Humans
(38)
Biological And Medical Sciences
(20)
Aids/hiv
(12)
Fundamental And Applied Biological Sciences. Psychology
(10)
Medical Sciences
(10)
Tumor Cells, Cultured
(10)
Virology
(10)
Animals
(9)
Biochemistry & Molecular Biology
(9)
Cell Line
(9)
Female
(9)
Male
(9)
Microbiology
(9)
Acetyltransferases - Genetics
(8)
Acetyltransferases - Metabolism
(8)
Immunology
(8)
Infectious Diseases
(8)
Amino Acid Sequence
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Preparation and characterization of human HIV type 1 neutralizing reference sera

Mutations in both gp120 and gp41 Are Responsible for the Broad Neutralization Resistance of Variant Human Immunodeficiency Virus Type 1 MN to Antibodies Directed at V3 and Non-V3 Epitopes

The phorbol ester phorbol myristate acetate inhibits human immunodeficiency virus type 1 envelope-mediated fusion by modulating an accessory component(s) in CD4-expressing cells

Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infection

Use of a sensitive neutralization assay to measure the prevalence of antibodies to the human immunodeficiency virus

Detection of human immunodeficiency virus core protein in plasma by enzyme immunoassay. Association of antigenemia with symptomatic disease and T-helper cell depletion

High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1MN in Sera from Africa and the Americas

CD4-derived synthetic peptide blocks the binding of HIV-1 GP120 to CD4-bearing cells and prevents HIV-1 infection

Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays

International collaborative study to compare assays for antibodies that neutralize human immunodeficiency virus

Human immunodeficiency virus neutralizing antibodies in sera from North Americans and Africans

Comparison of the Raji cell line fluorescent antibody to membrane antigen test and the enzyme-linked immunosorbent assay for determination of immunity to varicella-zoster virus

Mutations in both gp120 and gp41 are responsible for the broad neutralization resistance of variant human immunodeficiency virus type 1mn to antibodies directed at v3 and non-v3 epitopes

Chemically induced CD4 mutants of a human T cell line. Evidence for dissociation between binding of HIV I envelope and susceptibility to HIV I infection and syncytia formation

Evaluation of humoral immunity to varicella-zoster virus by an enhanced neutralization test and by the fluorescent antibody to membrane antigen test

Re-evaluation of the involvement of the adhesion molecules ICAM-1/LFA-1 in syncytia formation of HIV-1-infected subclones of a CEM T-cell leukemic line

The phorbol ester phorbol myristate acetate inhibits human immunodeficiency virus type 1 envelope-mediated fusion by modulating an accessory component(s) in CD4-expresssing cells

Varicella-zoster virus-specific HLA-restricted cytotoxicity of normal immune adult lymphocytes after in vitro stimulation

Study of viral replication in HIV-1-infected CEM T-cell subclones which are reduced in their ability to form syncytia: Clinical therapeutics in HIV disease

Study of viral replication in HIV-1-infected CEM T-cell subclones which are reduced in their ability to form syncytia

Ρe-evaluation of the involvement of the adhesion molecules ICAM-1/LFA-1 in syncytia formation of HIV-1-infected subclones of a CEM T-cell leukemic line

High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1 sub(MN) in sera from Africa and the Americas

Molecular landmarks of tumor hypoxia across cancer types

Risk factors for multidrug-resistant tuberculosis among tuberculosis patients in Serbia: a case-control study

Tailor-made biocatalysts based on scarcely studied acidic horseradish peroxidase for biodegradation of reactive dyes

Suchergebnisse filtern